Sort
46,585 grants matching “heart failure”
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A
$1,007,638Pamela Lutsey · University Of Minnesota · N01 · FY2024 · HL
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$1,007,340Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA
Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children
$1,007,115Will Clifton · Polyvascular Corporation · R44 · FY2021 · HL
Inhaled Fasudil and DETA NONOate CAR-Targeted Liposomes for PAH
$1,006,870Fakhrul Ahsan · Vascular Biosciences · R42 · FY2022 · HL
Subclinical Atrial Fibrillation and Supraventricular Ectopy in the Jackson Heart Study
$1,006,655James S Floyd · University Of Washington · R01 · FY2018 · HL
CBC-NO: SELECTIVE PULMONARY VASODILATOR FOR SEPSIS
$1,006,442Inotek Pharmaceuticals Corporation · R44 · FY2000 · GM
Revealing Cardiovascular Stress Regulation beyond the Diffraction Limit
$1,005,450Enrico Stefani · University Of California Los Angeles · R01 · FY2011 · HL
DMREF/Collaborative Research: High-Throughput Discovery, Development, and Demonstration of Material Systems to Enable Low-Power NEMS-Based Computation
$1,004,999Robert W Carpick · University Of Pennsylvania · · FY2013 · ENG
Multi-scale observation and modeling of IP3/Ca signaling
$1,004,677John E Pearson · Los Alamos Nat Secty-Los Alamos Nat Lab · R01 · FY2010 · GM
Insulin Resistance Intervention after Stroke (IRIS) Trial
$1,003,990Walter N Kernan · Yale University · U01 · FY2013 · NS
United States Renal Data System-Cardiovascular Special Studies Center
$1,003,555Charles Herzog · Hennepin Healthcare Research Institute · N01 · FY2009 · DK
CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patients
$1,003,424Harry Shamoon · Albert Einstein College Of Medicine · UL1 · FY2020 · TR
University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC)
$1,003,217Jay Steven Magaziner · University Of Maryland Baltimore · P30 · FY2021 · AG
A Novel, Low-Cost Mobile Metabolic Measurement (M3) System
$1,002,895B Eugene Parker · Barron Associates, Inc. · R44 · FY2025 · HL
Development of the Inspired Therapeutics NeoMate Mechanical Circulatory Support System for Neonates and Infants
$1,002,565Kurt A Dasse · Inspired Therapeutics, Llc · R44 · FY2022 · HL
Microfluidic cell squeezing platform for the transdifferentiation of somatic cells for efficient generation of a cell replacement therapy for Parkinsons Disease
$1,001,356Devin Bridgen · Sqz Biotechnologies Company, Inc. · R44 · FY2022 · GM
Completion of IND-enabling studies required for first-in-human studies of a novel oral therapeutic agent for treating pulmonary fibrosis
$1,000,618James Craig Hartman · Mdi Therapeutics, Inc. · R44 · FY2022 · HL
Diabetes and Heart Disease Risk in Blacks
$1,000,411Anne Sumner · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
GalT-KO Pigs Expressing Primate CD47 to Facilitate Organ Xenografts
$1,000,000Luis Queiroz · Mofa Group, Llc · R42 · FY2014 · AI
HISPANIC COMMUNITY HEALTH STUDY-STUDY OF LATINOS (HCHS-SOL)
$1,000,000Robert C Kaplan · Albert Einstein College Of Medicine · N01 · FY2023 · HL
GalT-KO Pigs Expressing Primate CD47 to Facilitate Organ Xenografts
$1,000,000Namdori Rachel Mtango · Minitube Of America · R42 · FY2012 · AI
Studying a Human Stem Cell Disease Using iPS Technology
$1,000,000Steven E Artandi · Stanford University · RC1 · FY2010 · HL
Ex Vivo Tolerance for Xenotransplantation of Diabetes P2
$1,000,000Patrick Eugene Kudlacek · Ximerex, Inc. · R44 · FY2012 · DK
Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy
$1,000,000Steven William Hetts · Filtro Medical Inc. · R42 · FY2024 · CA
Warfarin vs Aspirin in Reduced Ejection Fraction - STAT
$1,000,000John L Thompson · Columbia University Health Sciences · U01 · FY2010 · NS